Icelandic Salmon As (ISLAX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Icelandic Salmon As (ISLAX) has a cash flow conversion efficiency ratio of -0.043x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-5.40 Million ≈ $-568.03K USD) by net assets (Nkr125.33 Million ≈ $13.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Icelandic Salmon As - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Icelandic Salmon As's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ISLAX liabilities breakdown for a breakdown of total debt and financial obligations.
Icelandic Salmon As Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Icelandic Salmon As ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
American Oncology Network Inc.
NASDAQ:AONC
|
0.110x |
|
Zhonglu Co Ltd A
SHG:600818
|
-0.022x |
|
City Retail Developments Tbk PT
JK:NIRO
|
-0.006x |
|
Horizon Oil Ltd
AU:HZN
|
0.442x |
|
Dharma Polimetal Tbk PT
JK:DRMA
|
0.093x |
|
INVALDA INVL AB EO-29
F:WTK
|
N/A |
|
Genesco Inc
NYSE:GCO
|
-0.021x |
|
Anhui Yuanchen Environmental Protection Science & Technology Co. Ltd.
SHG:688659
|
0.059x |
Annual Cash Flow Conversion Efficiency for Icelandic Salmon As (2016–2025)
The table below shows the annual cash flow conversion efficiency of Icelandic Salmon As from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see ISLAX stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr125.00 Million ≈ $13.15 Million |
Nkr-22.09 Million ≈ $-2.32 Million |
-0.177x | -110.49% |
| 2024-12-31 | Nkr149.74 Million ≈ $15.76 Million |
Nkr-12.57 Million ≈ $-1.32 Million |
-0.084x | -131.99% |
| 2023-12-31 | Nkr152.88 Million ≈ $16.09 Million |
Nkr40.13 Million ≈ $4.22 Million |
0.263x | +225.83% |
| 2022-12-31 | Nkr144.22 Million ≈ $15.18 Million |
Nkr11.62 Million ≈ $1.22 Million |
0.081x | +4269.59% |
| 2021-12-31 | Nkr126.28 Million ≈ $13.29 Million |
Nkr-244.00K ≈ $-25.68K |
-0.002x | -121.55% |
| 2020-12-31 | Nkr108.18 Million ≈ $11.38 Million |
Nkr970.00K ≈ $102.07K |
0.009x | -92.25% |
| 2019-12-31 | Nkr66.08 Million ≈ $6.95 Million |
Nkr7.65 Million ≈ $804.79K |
0.116x | +269.99% |
| 2018-12-31 | Nkr64.44 Million ≈ $6.78 Million |
Nkr-4.39 Million ≈ $-461.74K |
-0.068x | +26.49% |
| 2017-12-31 | Nkr53.28 Million ≈ $5.61 Million |
Nkr-4.94 Million ≈ $-519.41K |
-0.093x | +54.09% |
| 2016-12-31 | Nkr54.64 Million ≈ $5.75 Million |
Nkr-11.02 Million ≈ $-1.16 Million |
-0.202x | -- |
About Icelandic Salmon As
Icelandic Salmon AS, together with its subsidiaries, engages in production, processing, and sale of salmon and salmon-based products in Europe, North America, and Asia. It is involved in the salmon farming activities. The company was formerly known as Arnarlax AS and changed its name to Icelandic Salmon AS in October 2020. Icelandic Salmon AS was founded in 2001 and is headquartered in Kverva, No… Read more